CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+0.63%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$911M
AUM Growth
+$911M
(-12%)
Cap. Flow
-$97.4M
Cap. Flow
% of AUM
-10.7%
Top 10 Holdings %
Top 10 Hldgs %
73.8%
Holding
28
New
5
Increased
6
Reduced
9
Closed
5
Top Buys
| 1 |
AtriCure
ATRC
|
$47.6M |
| 2 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$35.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$33.9M |
| 4 |
Myriad Genetics
MYGN
|
$24.7M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
$23.9M |
Top Sells
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$64M |
| 2 |
AKRX
Akorn, Inc.
AKRX
|
$60M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
$52.3M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$35.6M |
| 5 |
United Therapeutics
UTHR
|
$34.1M |
Sector Composition
| 1 | Healthcare | 95.96% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
| $121M | 13.32% | 2,730,887 -800,600 | -23% | -$35.6M |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $93.7M | 10.3% | 5,793,903 +2,095,000 | +57% | +$33.9M |
|
|
3
United Therapeutics
UTHR
$13.8B
| $83.3M | 9.15% | 580,701 -237,999 | -29% | -$34.1M |
|
|
AMRN
4
Amarin Corp
AMRN
$311M
| $77.2M | 8.47% | 25,052,380 +400,000 | +2% | +$1.23M |
|
|
MNK
5
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $57.5M | 6.31% | 1,153,944 -406,213 | -26% | -$20.2M |
|
6
Travere Therapeutics
TVTX
$1.56B
| $52.5M | 5.76% | 2,772,156 -312,791 | -10% | -$5.92M |
|
|
7
AtriCure
ATRC
$1.84B
| $52.2M | 5.73% | 2,666,354 +2,434,428 | +1,050% | +$47.6M |
|
8
Globus Medical
GMED
$8.27B
| $46.2M | 5.07% | 1,860,000 | – | – |
|
|
ARIA
9
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $44.2M | 4.86% | 3,553,943 -5,141,799 | -59% | -$64M |
|
10
Pediatrix Medical
MD
$1.5B
| $44M | 4.83% | 660,000 | – | – |
|
|
11
Myriad Genetics
MYGN
$593M
| $38.8M | 4.26% | 2,328,932 +1,478,932 | +174% | +$24.7M |
|
|
MACK
12
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $37M | 4.06% | 9,067,998 +3,117,773 | +52% | +$12.7M |
|
|
AMAG
13
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $35.7M | 3.92% | +1,026,902 | New | +$35.7M |
|
14
ANI Pharmaceuticals
ANIP
$2.03B
| $29.8M | 3.27% | 491,608 -161,650 | -25% | -$9.8M |
|
|
ARRY
15
DELISTED
Array Biopharma Inc
ARRY
| $23.9M | 2.63% | +2,723,471 | New | +$23.9M |
|
16
Pacira BioSciences
PCRX
$1.2B
| $20.4M | 2.24% | +631,805 | New | +$20.4M |
|
|
NVDQ
17
DELISTED
Novadaq Technologies Inc.
NVDQ
| $17.1M | 1.88% | +2,413,179 | New | +$17.1M |
|
18
Acadia Healthcare
ACHC
$2.12B
| $16.9M | 1.86% | +510,666 | New | +$16.9M |
|
19
Vericel Corp
VCEL
$1.83B
| $8.95M | 0.98% | 2,982,940 +750,000 | +34% | +$2.25M |
|
20
ADMA Biologics
ADMA
$4.12B
| $6.52M | 0.72% | 1,273,933 | – | – |
|
|
BIOL
21
DELISTED
Biolase, Inc.
BIOL
| $2.03M | 0.22% | 1,449,022 -341,970 | -19% | -$479K |
|
|
SPNE
22
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $1.01M | 0.11% | 128,127 -134,807 | -51% | -$1.06M |
|
23
Veracyte
VCYT
$2.39B
| $362K | 0.04% | 46,752 -119,073 | -72% | -$922K |
|
24
eHealth
EHTH
$118M
| – | – | -1,154,711 | Closed | -$12.9M |
|
25
HealthStream
HSTM
$832M
| – | – | -340,847 | Closed | -$9.41M |
|